Literature DB >> 1438749

Mammographic features of 455 invasive lobular carcinomas.

M Le Gal1, L Ollivier, B Asselain, M Meunier, M Laurent, P Vielh, S Neuenschwander.   

Abstract

Of 6,009 cases of breast cancer studied, 455 (7.6%) were invasive lobular carcinoma (ILC); 341 of these (75%) were pure ILC and 114 (25%) were ILC mixed with ductal forms. The mammographic features were compared with those of the 5,554 other breast carcinomas. Pure ILCs were less frequently round (1% vs 11%) and more frequently spicular (28% vs 23%) or with architectural distortion (18% vs 6%) than the other breast carcinomas. Microcalcifications were less common (24% vs 41%) and retraction of the skin (25% vs 21%) and nipple (26% vs 17%) was more common in pure ILC than in the other breast carcinomas. When complementary magnification views were obtained, only 50% were helpful in diagnosis of ILC while 75% were helpful in diagnosis of other breast carcinomas. Malignancy was less frequently diagnosed in ILC (57%) than in the other breast carcinomas (64%). The results were intermediate in the mixed ILC group.

Entities:  

Mesh:

Year:  1992        PMID: 1438749     DOI: 10.1148/radiology.185.3.1438749

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  25 in total

1.  MRI patterns of invasive lobular cancer: T1 and T2 features.

Authors:  G Levrini; C A Mori; R Vacondio; G Borasi; F Nicoli
Journal:  Radiol Med       Date:  2008-09-18       Impact factor: 3.469

Review 2.  CDH1 germline mutations and hereditary lobular breast cancer.

Authors:  Giovanni Corso; Mattia Intra; Chiara Trentin; Paolo Veronesi; Viviana Galimberti
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

3.  Invasive Lobular Carcinoma of the Breast: Appearance on Digital Breast Tomosynthesis.

Authors:  Ahuva Grubstein; Yael Rapson; Sara Morgenstern; Itai Gadiel; Amit Haboosheh; Rinat Yerushalmi; Maya Cohen
Journal:  Breast Care (Basel)       Date:  2016-10-12       Impact factor: 2.860

4.  Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.

Authors:  Louise M Henderson; Julie Weiss; Rebecca A Hubbard; Cristina O'Donoghue; Wendy B DeMartini; Diana S M Buist; Karla Kerlikowske; Martha Goodrich; Beth Virnig; Anna N A Tosteson; Constance D Lehman; Tracy Onega
Journal:  Breast J       Date:  2015-10-28       Impact factor: 2.431

5.  Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).

Authors:  Francesco Amato; Giulia Bicchierai; Donatello Cirone; Catherine Depretto; Federica Di Naro; Ermanno Vanzi; Gianfranco Scaperrotta; Tommaso Vincenzo Bartolotta; Vittorio Miele; Jacopo Nori
Journal:  Radiol Med       Date:  2019-11-26       Impact factor: 3.469

6.  Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.

Authors:  Aju Mathew; Padma S Rajagopal; Vipin Villgran; Gurprataap S Sandhu; Rachel C Jankowitz; Mini Jacob; Margaret Rosenzweig; Steffi Oesterreich; Adam Brufsky
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-06-28       Impact factor: 2.915

Review 7.  Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.

Authors:  Nikhil Pramod; Akanksha Nigam; Mustafa Basree; Resham Mawalkar; Saba Mehra; Neelam Shinde; Gary Tozbikian; Nicole Williams; Sarmila Majumder; Bhuvaneswari Ramaswamy
Journal:  Oncologist       Date:  2021-03-16

8.  Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.

Authors:  Foucauld Chamming's; Ellen Kao; Ann Aldis; Romuald Ferré; Atilla Omeroglu; Caroline Reinhold; Benoit Mesurolle
Journal:  Br J Radiol       Date:  2017-04-03       Impact factor: 3.039

9.  Sonomammographic characteristics of invasive lobular carcinoma.

Authors:  Osama R Kombar; Dalia M Fahmy; Mary V Brown; Omar Farouk; Osama El-Damshety
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-07-30

10.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.